Edition:
United Kingdom

Evofem Biosciences Inc (EVFM.OQ)

EVFM.OQ on NASDAQ Stock Exchange Capital Market

3.83USD
8:59pm GMT
Change (% chg)

$-0.17 (-4.25%)
Prev Close
$4.00
Open
$3.98
Day's High
$3.98
Day's Low
$3.83
Volume
2,551
Avg. Vol
24,406
52-wk High
$11.82
52-wk Low
$1.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.715
Jun '18 0.00 -1.114
Mar '18 0.00 -4.616
FY 2017 Dec '17 0.00 -1.023
Sep '17 0.00 -38.311
Jun '17 0.00 -3.780
Mar '17 0.00 -3.141
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Quarter Ending Jun-19 2 0.00 0.00 0.00 --
Year Ending Dec-19 5 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-19 3 -0.30 -0.27 -0.34 --
Quarter Ending Jun-19 3 -0.31 -0.26 -0.37 --
Year Ending Dec-19 5 -1.44 -1.13 -1.85 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.49 33.71
P/E High - Last 5 Yrs. -- 45.03 49.93
P/E Low - Last 5 Yrs. -- 23.66 24.27
Beta -- 0.90 0.90
Price to Sales (TTM) -- 4.12 6.28
Price to Book (MRQ) 0.97 5.11 5.27
Price to Tangible Book (MRQ) 0.97 5.85 6.78
Price to Cash Flow (TTM) -- 24.01 24.84
% Owned Institutions 38.12 0.91 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.13 4.83
Payout Ratio(TTM) -- 43.96 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.31 9.73
Sales (TTM) vs TTM 1 Yr. Ago -- 4.15 5.88
Sales - 5 Yr. Growth Rate -- 10.87 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -6.41 45.05 47.26
EPS (TTM) vs TTM 1 Yr. Ago 71.53 -- --
EPS - 5 Yr. Growth Rate -- 10.28 10.82
Capital Spending - 5 Yr. Growth Rate -- 15.84 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.25
Current Ratio (MRQ) 4.76 2.98 3.08
LT Debt to Equity (MRQ) 0.00 8.86 11.39
Total Debt to Equity (MRQ) 0.00 12.91 16.13
Interest Coverage (TTM) -32.50 33.85 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 53.65 53.79
Gross Margin - 5 Yr. Avg. -- 51.65 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.95 12.87
Operating Margin (TTM) -- 14.28 6.20
Operating Margin - 5 Yr. Avg. -- 14.22 8.31
Pre-Tax Margin (TTM) -- 14.84 7.17
Pre-Tax Margin - 5 Yr. Avg. -- 14.67 8.61
Net Profit Margin (TTM) -- 11.08 3.31
Net Profit Margin - 5 Yr. Avg. -- 11.02 4.89
Effective Tax Rate (TTM) -- 23.02 22.88
Effective Tax Rate - 5 Yr. Avg. -- 23.17 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 959,737,456 844,195,039
Net Income/Employee (TTM) -- 113,812,018 100,058,867
Receivable Turnover (TTM) -- 5.72 5.72
Inventory Turnover (TTM) -- 2.61 3.48
Asset Turnover (TTM) 0.00 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.00 11.55 11.08
Return on Assets - 5 Yr. Avg. -- 12.93 12.21
Return on Investment (TTM) -80.14 14.98 14.48
Return on Investment - 5 Yr. Avg. -- 16.85 15.88
Return on Equity (TTM) -90.12 16.30 15.99
Return on Equity - 5 Yr. Avg. -- 17.76 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 70.06 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Evofem Biosciences Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 36.63 31.92 97 22
13 Week -18.34 -22.32 17 39
26 Week -73.87 -75.85 2 33
52 Week -62.52 -68.23 6 9
YTD -59.17 -64.14 4 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 71.02%
# of Holders: 19
Total Shares Held: 18,370,460
3 Mo. Net Change: -2,274,929
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 3
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.